This treatment also increased the infiltration of CD8+ T cells and macrophages, as well as the mRNA expression levels of IL-12, IFN-γ, IL-2, IL-10, TNF-α, and PD-L1 in the tumor microenvironment. The gene discussed is IFNG; the disease is neoplasm.